Mark W. Elrod
Corporate Officer/Principal at Kowa Pharmaceuticals America, Inc.
Mark W. Elrod active positions
| Companies | Position | Start | End |
|---|---|---|---|
Kowa Pharmaceuticals America, Inc.
 Kowa Pharmaceuticals America, Inc. Pharmaceuticals: MajorHealth Technology Kowa Pharmaceuticals America, Inc. manufactures pharmaceutical products. It specializes in the areas of cardiology, pain and migraine. The firm also focuses on the acquisition, development, licensing, and marketing of pharmaceutical products. The company was founded in July 2008 by Carl Whatley and is headquartered in Montgomery, AL. | Corporate Officer/Principal | - | - |
Career history of Mark W. Elrod
Former positions of Mark W. Elrod
| Companies | Position | Start | End |
|---|---|---|---|
Flamel Technologies SA
 Flamel Technologies SA Pharmaceuticals: MajorHealth Technology Flamel Technologies SA engages in the research, development and commercialization of pharmaceutical products. Its portfolio includes Bloxiverz, Vazculep, Micropump, LiquiTime, Trigger Lock and Medusa. The company was founded by Gérard Soula in August 1990 and is headquartered in Vénissieux, France. | Sales & Marketing | 2016-09-08 | - |
Statistics
International
| United States | 2 |
| France | 2 |
Operational
| Corporate Officer/Principal | 1 |
| Sales & Marketing | 1 |
Sectoral
| Health Technology | 3 |
Positions held
Active
Inactive
Listed companies
Private companies
Linked companies
| Private companies | 2 |
|---|---|
Kowa Pharmaceuticals America, Inc.
Kowa Pharmaceuticals America, Inc. Pharmaceuticals: MajorHealth Technology Kowa Pharmaceuticals America, Inc. manufactures pharmaceutical products. It specializes in the areas of cardiology, pain and migraine. The firm also focuses on the acquisition, development, licensing, and marketing of pharmaceutical products. The company was founded in July 2008 by Carl Whatley and is headquartered in Montgomery, AL. | Health Technology |
Flamel Technologies SA
Flamel Technologies SA Pharmaceuticals: MajorHealth Technology Flamel Technologies SA engages in the research, development and commercialization of pharmaceutical products. Its portfolio includes Bloxiverz, Vazculep, Micropump, LiquiTime, Trigger Lock and Medusa. The company was founded by Gérard Soula in August 1990 and is headquartered in Vénissieux, France. | Health Technology |
- Stock Market
- Insiders
- Mark W. Elrod
- Experience
